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Stress Myocardial CT Perfusion
An Update and Future Perspective
Tust Techasith, BS,*† Ricardo C. Cury, MD‡
Boston, Massachusetts; and Miami, Florida
Coronary computed tomography angiography (CTA) has been shown by severalmulticenter trials to have
excellent diagnostic accuracy in the detection and exclusion of significant coronary stenosis. However, a
major limitation of coronary CTA is that the physiological significance of stenotic lesions identified is often
unknown. Stress myocardial computed tomography perfusion (CTP) is a novel examination that provides
both anatomic and physiological information (i.e., myocardial perfusion). Multiple single-center studies
have established the feasibility of stress myocardial CTP. Furthermore, it has been illustrated that a
combined CTA/CTP protocol improves the diagnostic accuracy to detect hemodynamic significant steno-
sis as compared with CTA alone; this combined protocol can also be accomplished at a radiation dose
comparable to nuclear myocardial perfusion imaging exams. Although initial results hold some promise,
stress myocardial CTP is a modality in its infancy. Further research is required to define, validate, and
optimize this new technique. However, it is a modality with significant potential, particularly in the
evaluation of chest pain patients, given the advantages of short exam time and comprehensive data
acquisition. This review highlights how to perform and interpret stress myocardial CTP, summarizes the
current literature, anddiscusses some future directions. (J AmColl Cardiol Img2011;4:905–16)©2011by
the American College of Cardiology Foundationdiac
cula
vant
.Recent advances in computed tomography
(CT) technology and the rapid evolution of
multidetector row CT (1), have allowed cardiac
imaging to flourish on this platform. Cardiac
CT has been proven to have numerous clini-
cally relevant applications, including coronary
artery calcium scoring, coronary computed to-
mography angiography (CTA), global and re-
gional left ventricular function assessment, and
most recently, the assessment of myocardial
CT perfusion (CTP) (2–6).
The majority of cardiac CT exams performed
today are coronary CTAs, aiming to elucidate the
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nary CTA has been shown by several multicenter
trials to have excellent diagnostic accuracy in the
detection and exclusion of significant coronary
stenosis (CAD) as compared with invasive coro-
nary angiography (6–8).
Despite its successes, coronary CTA has
several inherent limitations restricting its use to
a specific population. First and foremost, cor-
onary CTA only provides anatomic informa-
tion. Many studies have established that func-
tional information is essential in both guiding
clinical management and long-term prognosis
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906(9–11). The presence of anatomic lesions does not
necessarily correlate with functional abnormality—
that is, decreased myocardial perfusion (12). An-
other shortcoming of coronary CTA is its tendency
to overestimate the extent of CAD in high-risk
patients due to the presence of calcified plaques and
stents (13–14).
Given these shortcomings, many attempts have
been made to combine coronary CTA with func-
tional studies such as positron emission tomography
or single-photon emission computed tomography
(SPECT), illustrating complementarity between
the techniques (15,16). However, in such scenarios,
the patient is required to undergo at least 2 diagnostic
studies in order to arrive at the final result, which not
only is inconvenient but also subjects the
patient to increased radiation exposure. As
such, it is evident that a CT-based exam that
combines the information provided by anat-
omy and perfusion, namely stress myocardial
computed tomography perfusion (CTP) im-
aging, can have many potential benefits.
Recently, several single-center studies
have illustrated the feasibility of stress myo-
cardial CTP and have shown that stress
myocardial CTP adds incremental value to
traditional coronary CTA in the detection of
significant coronary stenosis, potentially
overcoming the limitations of coronary
CTA alone (17–20). Although initial results
hold some promise, stress myocardial CTP
is a modality in its infancy, with only a small
number of subjects evaluated overall, with
no clear optimized protocol as of yet. Fur-
ther research is required to define, validate,
and optimize this technique. However, it is a
modality with significant potential, particu-
larly in the evaluation of chest pain patients,
given the advantages of short exam time and compre-
hensive data acquisition. This review will address pro-
tocol setup and interpretation of stress myocardial CTP,
current literature, and future directions.
Protocol Setup and Interpretation of Stress
Myocardial CTP
Overview. Myocardial CTP protocol is composed
of a stress phase acquisition and a rest phase
acquisition, similar to a nuclear myocardial perfu-
sion imaging (MPI) exam. These acquisitions are
evaluated for myocardial perfusion information but
also coronary anatomy as well, generally using the rest
se
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ssionacquisition. Iodinated contrast is administered both in dthe stress and rest acquisition (60 to 75 ml for each
acquisition), for a total contrast dose of approximately
130 to 150 ml. Stress phase imaging is performed
under pharmacological administration of stress agents,
such as adenosine, dipyridamole, or regadenoson,
similar to nuclear medicine MPI. Additionally, a third
optional delayed-phase acquisition can be performed
in cases where late contrast enhancement evaluation
for myocardial scar is desired.
Patient preparation. In addition to the standard
etup of a coronary CTA, myocardial CTP protocol
equires a few additional components: namely, 1
dditional intravenous catheter if adenosine/
ipyridamole infusion is being used, a 12-lead elec-
rocardiogram (ECG) machine, and a blood pressure
onitor. Two 18- to 20-gauge intravenous catheters
re inserted into the patient’s antecubital veins: 1 for
he delivery of iodinated contrast material and the
ther for infusion of the pharmacological stress agent.
ctual gauge and site of insertion may vary depending
pon the patient’s anatomy. Contrast is prepared in a
ual-syringe contrast injection system. The pharma-
ological stress agent is prepared in an infusion pump.
ote is made that newer stress agents, such as regade-
oson, may require only 1 intravenous site for delivery
f the stress agent in a single bolus of 10 s followed by
saline flush. The contrast administration can be
iven after 1 to 2 min of regadenoson infusion. ECG
nd blood pressure measurements are performed prior
o scan acquisition to establish a baseline for patient
onitoring, during and after the procedure is
ompleted.
Choice of stress agents. Although it has been shown
n many studies that pharmacological and exercise
tress testing have comparable diagnostic character-
stics, exercise is the preferred method of stress in
yocardial perfusion imaging when possible (21–
5). This is due to its physiological mechanism and
ome reports of greater extent, severity, and revers-
bility of defects with exercise compared with phar-
acological stress (26,27). The main significant
imitation of exercise is that many patients, espe-
ially in a specific population that would benefit
rom a stress test, are not able to exercise ade-
uately. Additionally, all published literature on
tress myocardial CTP to date has employed phar-
acological stress. As such, this review will focus
n pharmacological stress agents; however, using
xercise stress in myocardial CTP is an area that
hould be explored in future studies.
Pharmacological stress agents that have been
alidated via feasibility trials include adenosine andA B B R E V I A T I O N S
A N D A C R O N YM S
CAD coronary artery disea
CTA computed tomograp
angiography
CTP computed tomograp
perfusion
DECT dual energy compu
tomography
ECG electrocardiogram
BFmyocardial blood flo
DCTmultidetector
omputed tomography
PImyocardial perfusion
imaging
NPV negative predictive v
PV positive predictive va
CA quantitative coronar
ngiography
PECT single-photon emiipyridamole (17–19). Both agents are coronary
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907vasodilators and work via coronary steal phenome-
non where the normal coronary arteries dilate more
than their diseased counterpart, leading to a differ-
ence in flow in the downstream myocardium and
highlighting the perfusion defect in the territory
supplied by the diseased artery. Exogenously ad-
ministered adenosine acts directly on adenosine
receptors, causing coronary vasodilation. Dipyri-
damole increases the level of endogenous adenosine
by decreasing the level of reuptake mechanism by
endothelial cells (28). Both adenosine and dipyri-
damole have been shown to have good sensitivity
and specificity for the detection of myocardial
perfusion defect with stress myocardial CTP. They
both have similar side effects profiles that include
reflex tachycardia and are similarly contraindicated in
patients with asthma, chronic obstructive pulmonary
disease, advanced atrioventricular block in the absence
of pacemaker, and caffeine use. Adenosine has a short
half-life in the seconds and is rapidly removed from
the body upon administration. Thus, it has a rapid
onset and short duration of action, and continuous
infusion is required for the purpose of myocardial
CTP. Dipyridamole is also administered using an
infusion pump; however, its effects last longer and,
unlike adenosine, may require reversal with an aden-
osine receptor antagonist such as aminophylline. Both
agents require weight-based dosing.
Other pharmacological stress agents have been
used for stress echocardiograms and nuclear stress
MPI but have not been fully validated in studies
evaluating myocardial CTP. For example, regade-
noson is a selective adenosine receptor agonist,
preferentially acting on the A2A receptor, leading to
elective coronary vasodilation and, therefore, lead-
ng to fewer side effects in patients with reactive
irway diseases. Regadenoson is easy to administer,
Table 1. Various Stress Agents and Their Advantages/Disadvan
Agent Advantage
Exercise Physiological
Least expensive
Pharmacological
Adenosine* Good sensitivity and speciﬁcity
Dipyridamole* Good sensitivity and speciﬁcity
Inexpensive
Regadenoson Easier dosing (10-s bolus)
Fewer side effects in patients with CO
Dobutamine Physiological mechanism
Increase oxygen consumption in the
*Stress myocardial CTP examinations with adenosine and dipyridamole have b
COPD  chronic obstructive pulmonary disease; CTP  computed tomography peiven as a standard dose with no need for weight
djustment, but has a prolonged effect. It may also
ause tachycardia, even more so than adenosine.
obutamine has been utilized mainly in stress
chocardiography and works via a more physiolog-
cal mechanism, by increasing the physiological
onsumption of oxygen in the myocardium leading
o induction of functional abnormalities. Advan-
ages and disadvantages of pharmacological stress
gents are summarized in Table 1.
Image acquisition. Scout images are acquired to
ocalize the heart position (Fig. 1). Contrast timing
or image acquisition is determined by using a contrast
aterial test bolus of 10 to 15 ml (flow rate: 4 to 5
l/s) followed by 20 ml of saline flush. The timing is
alculated by adding 2 to 4 s to the time of peak
ontrast enhancement in the ascending aorta, in order
o achieve a sufficient level of perfusion of contrast
aterial throughout the myocardium, from the sub-
picardial to the subendocardial layer and from the
ase to the apex of the heart. Alternatively, a trigger
olus method may be used where an attenuation-
ased threshold (Hounsfield unit [HU]) is set at a
pecific location, for example, 180 HU at the descend-
ng aorta, and image acquisition commences once the
ttenuation is met at that particular location.
There are 2 ways in which to set up a stress and
est myocardial CTP protocol based on the order of
can acquisition, namely, stress phase first followed
y rest phase, or vice versa. The main consideration
s that the first scan will be a “clean” acquisition, and
hat the contrast used in the first acquisition can
ross-contaminate the second acquisition if the
nterval between the scans is short (less than ap-
roximately 20 to 30 min) (Table 2). When doing
stress phase acquisition first, the detection of
yocardial ischemia is optimized by not having
s
Disadvantage
Motion ¡ Not validated using MDCT
Effort-dependent
Mild tachycardia
Contraindicated in patients with COPD, asth
Tachycardia
May requires aminophylline antagonism
Similar contraindications to adenosine
and asthma
Prolonged effects
Tachycardia
cardium
Lower sensitivity and speciﬁcity for perfusio
Tachycardia
Can provoke ischemia
used in preliminary trials.tage
ma, and caffeine use
PD
myo
n defects
een
rfusion; MDCT  multidetector computed tomography.
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908contamination of contrast; however, the second
scan can underestimate the presence of infarct in
the myocardium if a short scan interval is used.
Iodinated contrast has been shown to have similar
pharmacokinetics to gadolinium-based compounds
in magnetic resonance imaging (29). The contrast
from the stress scan would accumulate in an area of
myocardial infarct due to the slow wash-out phe-
nomenon, leading to possible underestimation of
myocardial infarction (perfusion defect during the
rest scan) if the second scan is done too early after
the first one (i.e.,10 min apart). A coronary CTA
cquisition can be acquired simultaneously with the
est acquisition, and beta-blockers and sublingual
itroglycerin can be given to optimize the second
can. For the patient population that myocardial
TP targets, it can be argued that obtaining accu-
ate stress phase images over rest phase is of utmost
mportance, because the primary aim of myocardial
TP is to detect myocardial ischemia. This impor-
ance of stress phase myocardial perfusion imaging
as been illustrated in previous studies evaluating
Figure 1. Full CTP Protocol
The protocol includes patient preparation and post-exam check (in
are as listed in sequence. Heart rhythm and symptoms are monitor
sion; ECG  electrocardiogram; IV  intravenous.
and Disadvantages of Different CTP Protocol Sequences
Advantages
Better sensitivity of stress scan (ability to detect ischemia)
Coronary CTA can be optimized with second acquisition by giving
medications without interfering with perfusion assessment
Ability to stop protocol after rest phase (if no or minimal disease
is evident)
Better sensitivity of rest scan (ability to detect infarct)aphy angiography; CTP  computed tomography perfusion.SPECT (30); going forward, it will be important to
verify these findings for myocardial CTP as well.
Moreover, there are subsets of patients that would
benefit from a stress perfusion study first, such as
patients with intermediate to high pre-test proba-
bility of CAD; patients with high calcium scores
(i.e., calcium score 400); patients with known
AD; patients with prior myocardial infarct; or any
ther situation where simultaneous evaluation of a
tenotic coronary vessel leading to ischemia is im-
ortant to define revascularization options.
On the other hand, performing rest phase acqui-
ition/CTA first could make sense in clinical prac-
ice if the decision to proceed to stress myocardial
TP would be guided by the CTA results, meaning
hat stress myocardial CTP would only be per-
ormed if a moderate or severe coronary stenosis
ould be found or if there is any nondiagnostic
egment (calcified lesions or stents). The potential
ssues of this approach are 2-fold: first, the cross-
ontamination of contrast in the second acquisition
stress phase), potentially masking areas of ischemic
ing an optional delayed phase acquisition (shaded box). All steps
hroughout the entire exam. CTP  computed tomography perfu-
Disadvantages
Contrast contamination, leading to appearance of late contrast
enhancement during rest acquisition (decreased sensitivity
for infarct)
Contrast contamination, leading to appearance of late contrast
enhancement during stress acquisition (decreased sensitivity
for ischemia)
Beta-blocker given during ﬁrst acquisition can underestimate
myocardial ischemiaclud
ed tTable 2. Advantages
Sequence
Stress ¡ Rest
Rest ¡ Stress
b
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909myocardium (reversible stress perfusion defect) as
illustrated in Figure 2; and second, the use of
eta-blockers to optimize image quality of coronary
TA in the first acquisition could also lead to
nderestimation of myocardial ischemia. The first
ssue can be avoided by having an interval of at least
0 min between the rest and stress acquisition to
llow washout of contrast from the myocardium.
he second issue can be avoided if the temporal
esolution of CT scanners keeps improving, allevi-
ting the need to use beta-blockers. In summary, for
uture implementation of stress myocardial CTP, it
ay be advantageous to stratify patients into low-
isk and high-risk groups. The low-risk group
ould undergo a rest phase scan first with the aim
f ruling out CAD, whereas the high-risk group
ould start with the stress phase scan for detection
f myocardial ischemia and then an optimized
TA/rest myocardial CTP exam with a beta-
locker and nitroglycerin can be acquired.
For the stress phase acquisition, infusion of the
harmacological stress agent is initiated (with a rate of
40 g/kg/min for adenosine infused over 3 to 4 min
nd 0.56 mg/kg of dipyridamole infused over 4 to 6
in). When the pharmacological stress agent reaches
Figure 2. Contrast Contamination of Stress Acquisition Leading
Patient underwent a computed tomography perfusion (CTP) protoc
Shows the rest acquisition revealing a perfusion defect inferiorly. (B
trast administration, leading to the appearance of a smaller area of
defect on single-photon emission computed tomography (SPECT). A
ticular example, it is easy to imagine that an area of stress-induced
formed second. Of note, there is gastric uptake in (C); however, this didts peak, 60 to 70 ml of contrast is delivered at 4 to 5
l/s. The stress phase scan is then acquired using the
reviously derived timing or the trigger bolus method.
he stress phase scan can be acquired using a retro-
pectively gated scan with ECG tube current modu-
ation. Tube voltage of 100 kV is used for patients
ith body mass index of 30 kg/m2 and 120 kV for
ody mass index30 kg/m2. Tube current can also be
adopted depending on the patient’s body habitus.
Throughout the entire process, the patient’s symp-
toms, heart rate, blood pressure, and ECG are closely
monitored. The pharmacological stress agent is
stopped immediately after the stress phase acquisition
(or reversed in case of dipyridamole).
If the rest phase acquisition follows the stress
phase acquisition, there should be a period of delay
(at least 20 min) in order for the effects of the
pharmacologic stress to resolve. Resolution of
symptoms and return of heart rate to baseline can be
used as a proxy to judge when the effects have
resolved. For the rest acquisition, another 60 to 70
ml of contrast is again delivered at 4 to 5 ml/s;
the acquisition employs similar timing as the stress
acquisition. Unlike the stress acquisition, the rest
acquisition is performed via prospective ECG
a False Negative
ith rest acquisition followed by stress acquisition 10 min later. (A)
veals a stress acquisition that is contaminated by previous con-
ect during stress. (C,D) Reveal a ﬁxed, inferior wall perfusion
ugh SPECT did not reveal any ischemic myocardium in this par-
emia can be missed on CTP if the stress phase acquisition is per-to
ol w
) Re
def
ltho
ischnot interfere with the interpretation in this case.
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910triggering at mid-diastole to minimize radiation
dose, but the tube voltage and current settings were
similar to those used for the stress scan. This phase
can be used to assess both the coronary arteries and
rest myocardial CTP. Beta-blockade with intrave-
nous metoprolol can be administered, as in the case
of traditional CTA protocol, to optimize the visu-
alization of coronary anatomy by decreasing the heart
rate. Studies evaluating the feasibility of myocardial
CTP have been conducted with and without the use
of beta-blockers, all showing comparable results (17–
19). The administration of nitroglycerin can also be
used to achieve coronary vasodilation. However, it
should be noted that nitroglycerin is known to affect
myocardial perfusion, and thus may interfere with the
accuracy of the study (31).
A third scan can be added to assess for delayed
enhancement (i.e., myocardial infarct) This acqui-
sition is performed approximately 5 to 10 min after
the completion of the second (either stress or rest)
acquisition. No contrast injection is needed for this
phase, as it employs previously injected contrast in
the stress and rest phases. The acquisition is pro-
spectively ECG-triggered at mid-diastole of the
cardiac cycle, similar to the rest phase scan. Tube
voltage is set to 100 kV; tube current settings are
similar to those used for the stress and rest scan.
Finally, post-exam ECG and blood pressure mea-
surements are performed to ensure patient’s safety.
The necessity and the value of the delayed phase
scan as part of myocardial CTP has not been well
established at this point. Gerber et al. (29) illus-
trated the similar pharmacokinetics between iodin-
ated contrast and gadolinium in infarcted myocar-
dium over a decade ago. Since then, it has been
shown in patients that CT delayed enhancement
can be detected in infarcted myocardium, but with
relatively poorer signal-to-noise and contrast-to-
noise ratios (32). Blankstein et al. (18). found that
delayed enhancement on CT correlated well with
rest perfusion defect on SPECT as a part of
comprehensive myocardial CTP protocol; however,
this comparison was done only in subjects with
favorable image quality. There is also additional
radiation exposure to the patient, though this is
relatively low (approximately 1 mSv or less) when
prospective triggering and low tube voltage is used.
Overall, there is not enough literature to definitively
support the incorporation of a delayed phase scan as
a part of myocardial CTP protocol; however, fur-
ther research on the use of delayed enhancement
CT for viability evaluation is needed.Image processing and interpretation. Raw scan data
rom the 2 or 3 phases (stress, rest, and delayed) are
econstructed into axial image datasets at mid-
iastole, using a smooth filter with slice thickness of
.7 mm and overlap of 0.4 mm. The axial images
re then used to create short-axis, 2-chamber, and
-chamber views by multiplanar reconstruction.
hicker reconstruction (8 to 10 mm) of average
ultiplanar reformation is preferred for the detec-
ion of perfusion defect. Minimum-intensity pro-
ections may be more sensitive in bringing out
ubtle perfusion defects; however, it is also more
usceptible to increased noise and false positives
33). Maximum intensity projections are not useful,
s they mask perfusion defects. Images are co-
egistered and read in a side-by-side fashion (see
ig. 3 for an example). Narrow window width
100 to 200 HU) should be used centered at
ttenuation of around 100 HU (window level).
There is a direct relationship between the
mount of iodinated contrast within the myocar-
ium and myocardial attenuation (HU). As such, a
elative difference in myocardial perfusion can be
isualized as differing attenuations; areas of myo-
ardium with decreased blood flow would have a
ower attenuation—a perfusion defect. When pres-
nt, a perfusion defect can usually be detected
isually; confirmation with region of interest mea-
urements can be helpful. The interpretation of
erfusion defect while under stress and/or at rest
i.e., ischemia and/or infarct) in myocardial CTP is
imilar to the interpretation of nuclear MPI, with
eversibility serving as the key distinguishing fea-
ure. A simple guide to myocardial CTP interpre-
ation is shown in Figure 4.
For the interpretation of delayed phase acquisi-
ion, the fundamental guiding principle is the sim-
lar pharmacokinetics between iodinated contrast
sed in CT and the gadolinium-based contrast used
n magnetic resonance. Time-dependent contrast
atterns characterizing myocardial infarct have been
stablished with both contrast agents, with first-
ass hypoenhancement due to decreased contrast
elivery to the infarcted region and delayed en-
ancement secondary to increased distribution vol-
me and altered contrast pharmacokinetics in dead
yocardial tissue (29,34).
Review of the Literature
The concept of CT examination for myocardial
perfusion defect was first investigated in 1978
soon after the advent of the modality (35).
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911However, the reliable use of CT to detect myo-
cardial perfusion defect has only been achieved
with the recent advancements in CT technology.
The first attempt to use multidetector CT to
characterize myocardial perfusion defects in hu-
man under stress was first explored by Kurata et
al. in 2005 (36), using adenosine stress on a
16-detector multidetector computed tomography
(MDCT) scanner. Although the study showed
good agreement between myocardial CTP and
Figure 3. Comparison of CTP, SPECT, and Invasive Coronary An
Shown is a 55-year-old man with history of hypertension and hype
exertion. SPECT myocardial perfusion imaging illustrated partially re
els: top  stress, bottom  rest). CTP illustrates similar defects (mi
tion, occlusion in the left anterior descending (bottom right) and s
are seen. Abbreviations as in Figure 2.
Figure 4. Basic Guide to Interpretation of CTP
A perfusion defect under pharmacological stress that reverses at re
is characteristic of myocardial infarction. Note that myocardial infar
late gadolinium enhancement in cardiac magnetic resonance. CTP  cothallium-201 myocardial perfusion scintigraphy,
only 48% of coronary segments were evaluable
under stress (compared with 89% at rest, p 
0.05), illustrating that myocardial CTP was not
feasible at that time due to the limitations in the
temporal resolution. Since then, numerous stud-
ies have been performed to evaluate the feasibility
of stress myocardial CTP in both animal models
and humans with newer generation of scanners
showing improved results.
raphy
emia who presented with symptoms of substernal chest pain on
ible anterior, anteroseptal, and lateral perfusion defect (left pan-
panels: top  stress, bottom  rest). Upon cardiac catheteriza-
ﬁcant stenosis in the left circumﬂex (top right) coronary arteries
, by deﬁnition, stress-induced ischemia. A ﬁxed (irreversible defect)
also exhibits late contrast enhancement in a fashion similar togiog
rlipid
vers
ddle
ignist is
ctionmputed tomography perfusion.
DSCT  dual source comp ardi
abbreviations as in Tables
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912The first animal studies illustrating feasibility of
myocardial CTP using MDCT were performed by
George et al. (37,38) in canine models (Table 3).
These studies established the semiquantitative rela-
tionship between CT attenuation and blood flow
based on microsphere myocardial blood flow
(MBF). Further work in a porcine model has
confirmed that coronary flow reserve measurements
by microsphere MBF and myocardial CTP correlate
well with each other (39). In human studies, results
from multiple cohorts employing different scanners
and pharmacological stress agents (Table 4) seem to
confirm the initial findings of animal studies. It
should be noted that these initial studies are con-
ducted at various institutions with differences in
protocols and reference standards. The unifying
theme, however, is that perfusion defects on myo-
cardial CTP seem to correlate well with perfusion
Animal Studies Evaluating Myocardial Stress CTP
al Model CTP Protocol Reference Standard
e (n  8)
tenosis
Adenosine stress
64-detector MDCT
Microsphere MBF Linea
sig
att
att
e (n  6)
stenosis
Adenosine stress
64-detector MDCT
Microsphere MBF MDCT
wi
p 
ne (n  8) Adenosine stress
64-detector MDCT
Microsphere MBF Signi
co
be
(r
ne (n  10)
stenosis
al control
Adenosine stress
128-detector DSCT
Dynamic scan mode
— No si
MB
co
sig
ad
uted tomography; LAD  left anterior descending coronary artery; MBF  myoc
Human Studies Evaluating Myocardial Stress CTP
ef. #) Scanner Type Comparison* Steno
) 64/256-MDCT CTA/CTP vs. QCA/SPECT 
(18) DSCT CTP and SPECT vs. QCA 
0 (20) DSCT CTA/CTP vs. QCA 
64-MDCT CTP and SPECT vs. QCA 
2nd-generation DSCT Dynamic CTP vs. SPECT/QCA
DSCT DECT vs. CMR/QCA
5
ns and reference standards vary widely. †Stenosis (%) refers to the stenosis thre
resonance; NPV  negative predictive value; PPV  positive predictive value; Q
1 and 3.defects on SPECT, stenoses on quantitative coro-
nary angiography (QCA), or both. For further
details on reference standards used, refer to Table 4.
George et al. (17) used adenosine as the pharma-
cological stress agent, beta-blockers for heart rate
control, and 64-detector MDCT or 256-detector
MDCT for image acquisition. The combined anal-
ysis of all patients (including both scanner types) in
this study showed a per-vessel territory sensitivity,
specificity, positive predictive value (PPV), and
negative predictive value (NPV) of 75%, 87%, 60%,
and 93%, respectively, when compared with QCA
and SPECT. The potential limitations of this study
are nonuniformity of protocols and use of beta-
blockers, which may have blunted the degree of
difference in perfusion between the ischemic and
the nonischemic heart. Blankstein et al. (18) ac-
quired myocardial CTP images under adenosine
Results Conclusion
ationship between myocardial
density ratio (myocardial
ation/left ventricular
ation)
Adenosine stress MDCT provides
semi-quantitative measurements
of myocardial perfusion in
canine model of LAD stenosis
rived MBF strongly correlated
icrospheres (R  0.91,
0001)
MDCT MBF measurements using
upslope and model-based
deconvolution methods
correlate well with
microsphere MBF
t correlation between
ry ﬂow reserve measurements
en microsphere MBF and CT
94, p  0.0001)
CT ﬁrst-pass myocardial
perfusion imaging is feasible
using a simple semi-
quantitative analysis which
provides reasonable
estimates of MBF.
cant differences in CT-based
etween the stenotic and
l group at rest; however,
ant difference under
sine stress (p  0.0024).
DSCT permits quantitative
whole heart perfusion
imaging, with ability to show
hemodynamic effect of high
grade coronary artery
stenosis.
al blood ﬂow; other abbreviations as in Tables 1 and 2.
(%)† n mSv Sn (%) Sp (%) PPV (%) NPV (%)
27 16.8 (64)
21.6 (256)
86 92 92 85
33 12.7 92 67 89 75
34 11.8 96 100 100 91
36 14.7 94 75 89 86
35 18.2 95 65 78 79
50 — 89 76 — —
215 11.8–21.6 86–96 67–100 78–100 79–91
used in studies which employed QCA as a part of the reference standard.
 quantitative coronary angiography; Sn  sensitivity; Sp  speciﬁcity; otherTable 3. Summary of
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913stress using a dual source CT scanner, which has
higher temporal resolution, obviating the need for
beta blockade. The comprehensive myocardial CTP
protocol also uniformly included a rest and a de-
layed phase acquisition in all study subjects. The
results showed that myocardial CTP is equivalent
to SPECT in detecting coronary artery stenosis by
QCA, with per-vessel territory sensitivity and spec-
ificity of 79% and 80% for myocardial CTP and
67% and 83% for SPECT, respectively (p  NS).
urthermore, the CTA obtained during the stress
hase of the scan was excellent for diagnosing
tenosis of 70% or more on QCA. The study also
llustrated that the full myocardial CTP protocol
an be done at similar radiation exposure to
PECT MPI (12.7 mSv for both). Subsequent
tudies based on the same cohort further confirmed
he feasibility and value of myocardial CTP. Rocha-
ilho et al. (20) demonstrated that adding perfusion
nformation obtained from stress myocardial CTP
o coronary CTA improves all diagnostic character-
stics of CTA alone, particularly specificity and
PV. Okada et al. (40) illustrated the concordance
etween myocardial CTP and SPECT in the de-
ection and evaluation of size and severity of myo-
ardial perfusion defects at stress and at rest. In
nother cohort of patients, Tamarappoo et al. (41)
ompared the extent and severity of perfusion de-
ects between myocardial CTP and SPECT using a
-point scale and a total perfusion deficit score. For
oth methods, good agreement was achieved. Cury
t al. (19) employed a different stress agent, dipyr-
damole, on a 64-detector MDCT scanner. Their
esults also demonstrated that myocardial CTP is at
east equivalent to SPECT in the detection of
tenosis found on QCA (sensitivity and specificity:
8% and 79% for myocardial CTP and 69% and
1% for SPECT, p  NS).
Recently introduced dual energy mode and dy-
amic scan mode have also been investigated for the
etection of perfusion defects (42–44). Dual energy
can mode takes advantage of the fact that different
aterials have different spectral characteristics
hen penetrated by different x-ray energy levels;
his allows for the mapping of iodine concentration
ithin the myocardium—potentially reflecting the
egree of myocardium perfusion (45). Initial investi-
ation by Ruzsics et al. (42) demonstrated that dual
nergy computed tomography (DECT) had a sensi-
ivity and specificity of 96% and 95% in detecting fixed
erfusion defect seen on SPECT. Furthermore,
ECT had a sensitivity and specificity of 88% and9%, respectively, for the detection of reversible per-usion defect (42), although the physiological mecha-
ism behind such a concordance remains controversial
s DECT was not performed under stress in the
tudy. Most recently, Ko et al. (46), in a study of
ECT in the setting of adenosine stress, illustrated
hat DECT had a sensitivity, specificity, and accuracy
f 89%, 78%, and 82%, respectively, for the detection
f myocardial segments with perfusion defect, using
tress perfusion MRI as the gold standard.
Preliminary experiences with dynamic myocardial
T perfusion imaging also showed good promise in
oth animal models and human patients. Mahnken et
l. (43) illustrated the ability of dynamic quantitative
hole-heart perfusion imaging to detect the hemody-
amic effect of high-grade coronary artery stenosis in
canine model. Furthermore, in an early experience
ith a patient cohort, Ho et al. (44) demonstrated that
tress and rest dynamic perfusion imaging can detect
yocardial perfusion defect with good diagnostic
ccuracy when compared with SPECT MPI (per-
egment sensitivity, specificity, PPV, and NPV of
3%, 78%, 79%, and 82%, respectively) and with
CA (per-segment sensitivity, specificity, PPV, and
PV of 95%, 65%, 78%, and 79%, respectively) and
llows for defining time-attenuation curves with the
otential for quantification of myocardial blood flow.
owever, it should be noted that the radiation dose
or this protocol (around 20 mSv) is much higher than
tatic myocardial CTP. Furthermore, the use of qual-
tative SPECT as a reference standard is suboptimal
or such analysis (47).
Study limitations. Myocardial CTP as a modality
still has a number of limitations, some of which
will eventually be overcome as CT technology
improves. There are a few CT-related artifacts
that the physician should recognize and try to
minimize when performing and interpreting myo-
cardial CTP, namely beam-hardening and motion
artifacts.
Beam hardening is a phenomenon that occurs
when x-ray beams pass through objects of high
density, leading to a selective attenuation of lower-
energy beams and increased mean energy of the
remaining beams. The resulting appearance is a
hypoenhanced region that may mimic areas of true
perfusion defect. There are a few characteristics that
physicians can use to help identify beam-hardening
artifacts. The hypoenhanced region is usually trian-
gular in shape, appears to originate from the region
of high attenuation next to it, and does not conform
to vascular territories (37). A particularly common
location includes the basal inferolateral wall, due to
proximity to the descending aorta with iodinated
C
K
r
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914contrast and dense vertebral bodies. Attempts to
develop an algorithm to minimize beam-hardening
artifacts are ongoing, with the use of iterative
reconstruction.
Myocardial CTP is also prone to motion artifacts
similar to coronary CTA, particularly during the
stress phase acquisition, due to the increased heart
rate. Cardiac motion during the acquisition leads to
hypoenhanced areas that can mimic true perfusion
defects. Motion artifacts are becoming less of an
issue as the temporal resolution of CT continues to
improve. Moreover, by assessing multiple phases of
the cardiac cycle, one might be able to differentiate
a true perfusion defect from an artifact as the
perfusion defect will persist and the artifact will
disappear or change in location. Regional wall
motion abnormalities can also be detected associ-
ated with true perfusion defects. Table 5 lists
helpful tips in distinguishing artifacts from true
perfusion defects.
Conclusions and Future Directions
The feasibility of stress myocardial CTP as a clinical
entity has thus far been evaluated in animal models
and single-center prospective patient cohort studies
nguish Artifacts From True Perfusion Defects
Tips
s not correspond to a vascular territory
s not correspond with wall motion abnormality in the same
egment
s not persist across different phases of the cardiac cycle
e as motion artifact above
usion defect in early arterial phase due to the presence of high
ose of dense contrast in the ventricle
usion defect in the basal inferolateral wall due to the proximity of
he dense spine and contrast in the descending aorta
usion defect that is triangular in shape, originating from the
egion of high attenuation in the proximityprospective triggering with dual- assessment and in ev64-MDCT and newer scanners have been promis-
ing, showing that myocardial CTP has comparable
diagnostic characteristics to SPECT MPI in the
detection of myocardial perfusion defects. Further-
more, myocardial CTP protocol allows for the
simultaneous acquisition of coronary anatomy and
myocardial perfusion, and a combined CTA/CTP
protocol has been shown to have better diagnostic
characteristics than CTA alone. The radiation ex-
posure in such protocols is similar to that of a
traditional SPECT MPI exam; the radiation
exposure is also likely to decrease as CT technol-
ogy advances (18). These data suggest that myo-
cardial CTP has the potential to become a robust
clinical tool for the evaluation of chest pain
patients. However, it should be noted that the
modality is in a very early stage of development.
Published studies are composed only of single-
center preliminary experiences. All evaluated co-
horts thus far are based on a referral population of
patients with intermediate to high pre-test prob-
ability of CAD and patients referred to other
tests such as SPECT MPI and cardiac catheter-
ization. Furthermore, no standardized protocol
currently exists for myocardial CTP studies as the
feasibility studies all utilized varying protocols.
More research is needed in order to further
define, optimize, and validate the modality. Par-
ticularly, a prospective multicenter, multivendor
trial evaluating the diagnostic characteristics of
myocardial CTP in a wider patient population is
needed to confirm the findings of these promising
preliminary trials in order to establish myocardial
CTP as a viable clinical option.
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